Skip to main content
. 2020 Sep 3;12:53. doi: 10.1186/s13102-020-00205-9

Table 3.

Data from the exercise test of the study participants who completed baseline and follow up testing (n = 55) presented by before treatment and after six month follow up, stratified by treatment group. Data are given as mean with confidence intervals (CI) and standard deviation (SD) in parentheses unless otherwise stated*

Before treatment mean (SD) 95% CI Six month follow up mean (SD) 95% CI P-valueb
Chemotherapy (N = 20) VO2max (ml kg−1. min− 1) 31 (7.1) 27.6–34.3 28.7 (6.2) 25.8–31.6 .191
VE peak (L min− 1) 84 (15.4) 76.8–91.2 82.4 (19.4) 73.3–91.5 .296
RER peak 1.25 (0.1) 1.22–1.29 1.22 (0.1) 1.17–1.27 .147
RPE peak 17.2 (1.2) 16.6–17.8 17.8 (1.2) 17.2–18.3 .058
HR peak (beats. min−1) 173 (13) 166.5–178.6 170 (11.1) 164.3–174.6 .054
Radiotherapy (N = 18) VO2max (ml kg−1. min− 1) 29.4 (6.7) 26.1–32.7 29.4 (7.9) 25.5–33.3 .794
VE peak (L min− 1) 77.8 (18.7) 68.5–87.1 73.5 (28.2) 59.4–87.5 .845
RER peak 1.20 (0.1) 1.15–1.25 1.17 (0.1) 1.12–1.23 .140
RPE peak 16.6 (1.3) 15.9–17.2 17.2 (1.5) 16.4–17.9 .031*
HR peak (beats. min−1) 169 (20.4) 158.6–178.9 165 (16.4) 156.7–173 .138
Endocrine therapy (N = 17) VO2max (ml kg− 1. min− 1) 32 (6.8) 28.5–35.5 33.1 (9.2) 28.4–37.8 .162
VE peak (L min− 1) 86.6 (18.6) 77.1–96.2 83.7 (17.2) 74.8–92.5 .113
RER peak 1.23 (0.1) 1.16–1.30 1.19 (0.1) 1.13–1.24 .162
RPE peak 17.4 (1.2) 16.8–18 17.2 (1.7) 16.3–18.1 .558
HR peak (beats. min−1) 166 (17.8) 156.9–175.2 166 (19.7) 156.2–176.4 .816

a Abbreviations: VO2max, highest recorded oxygen uptake during exercise test; VE peak, highest recorded ventilation; RER peak, highest recorded respiratory exchange ratio; RPE peak, highest reported perceived exertion; HR peak, highest recorded heart rate; MVPA, Moderate and vigorous physical activity

b P-values for any differences between groups